Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stocks: Larry Feinberg Buys at Accelerate Diagnostics, China Pioneer Pharma Buys at NovaBay

By

Plus, purchases at Boulder Brands and Noble.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • Larry Feinberg, founder of Oracle Investment Management and co-owner of in vitro diagnostics company Accelerate Diagnostics (NASDAQ:AXDX), bought 297,618 shares of company stock for $4,999,983.
  • China Pioneer Pharma Holdings (HKG:1345), a marketing, promotion, and channel management service provider of imported pharmaceutical products and medical devices and a partner with clinical-stage biopharmaceutical company NovaBay Pharmaceuticals (NYSEMKT:NBY), bought 500,000 shares of company stock for $495,000.
  • Benjamin D. Chereskin, an investment professional on the board of directors for US food company Boulder Brands (NASDAQ:BDBD), bought 25,000 shares of company stock for $334,250.
  • David W. Williams, chairman of the board and president of Noble Corp. (NYSE:NE), a major contract driller of oil and natural gas wells, bought 10,000 shares of company stock for $306,400.
For more insider trades, see the charts below.

Insider Purchases

#:
Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
JB*
$5,500,000
2
BO
JB*
$4,999,983
3
O
B
$2,613,664
4
BO
B
$896,604
5
O
B
$735,726
6
BO
B
$495,000
7
CEO,DIR
B
$350,800
8
O
B
$334,841
9
DIR
B
$334,250
10
CB,CEO,DIR
B
$306,400

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
JS*
$76,434,960
2
MD,DIR,BO
AS
$28,560,614
3
DIR,BO
JS*
$23,400,000
4
BO
JS*
$22,413,278
5
BO
S
$11,996,557
6
F,DIR
AS
$11,172,703
7
F,DIR
AS
$11,137,490
8
CEO,F,CB
AS
$8,347,117
9
BO
S
$5,234,520
10
DIR,BO
S
$4,587,500

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."

No positions in stocks mentioned.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE